us neurovascular intervention market

8/16/2019 us neurovascular intervention market

1/7

Analysis of the US Neurovascular Intervention Market

Large Opportunities in Expanding Treatment Options and New Technologies

NC3F-54

July 2013


2/7

4NC3F-54

Executive Summary


3/7

5NC3F-54

• Total revenue generated by sales of neurovascular intervention market in the US in

2012 was approximately $273.0 million.

• Revenue in the US neurovascular intervention market is projected to grow at a

compound annual growth rate (CAGR) of 7.6 percent from 2012 to 2017, reaching

$392.8 million in 2017.

• Currently, the largest market segment is the neurovascular coils market, while the

smallest is the liquid embolics market.

• The segment with the highest CAGR is the stent retriever market, since the first stent

retriever in the US was launched in early 2012. More stent retrievers are expected to

enter the US market in the coming years.

• The high growth rate in the stent retriever market is likely to offset the trends in the

relatively stable coils and liquid embolics markets, leading to the growth of the overall

neurovascular intervention market.

Source: Frost & Sullivan

Executive Summary


4/76NC3F-54

• There is great uncertainty surrounding the future of the neurovascular coils segment

because of emerging flow-diversion devices’ potential to become both a complement

and a substitute to coils for aneurysm treatment.

• The US liquid embolics segment is essentially a monopoly as the Food and Drug

Administration (FDA) has placed the only product available under very restricted use

for fewer than 4,000 patients in the US.

• Ischemic stroke patients had been previously underserved with only one treatmentoption; thus, companies are now eager to develop and introduce stent retrievers to the

US market with a large patient base and high growth potential.

• The overall US neurovascular intervention market is very concentrated with only a fewlarge manufacturers because of high barriers to entry, most notably the 510(k)

clearance required from the US FDA.

Executive Summary (continued)



5/77NC3F-54

Compound

Annual Growth

Rate

7.6%

(CAGR, 2012 –2017)

Market Stage

Growth

Market Revenue

$273.0 M

(2012)

Market

Units/Volume

174,257

(2012)

Average Price*

$2,890.9

Market Size for

Last Year of

Study Period

$392.8

(2017)

Base Year

Market Growth

Rate

24.6%

Customer Price

Sensitivity

7

(scale:1 [Low] to 10 [High])

Degree of

Technical

Change

6

(scale:1 [Low] to 10 [High])

Total Neurovascular Intervention Market: US, 2012

For a tabular version click here.

Stable IncreasingDecreasing *Weighted Average Selling Price

Executive Summary—Market Engineering Measurements

Market Overview

Note: All figures are rounded. The base year is 2012. Source: Frost & Sullivan


6/78NC3F-54

AverageProduct

DevelopmentTime

5Years

Number of

Companies thatEntered

0

(2012)

Number of

Competitors*

About 10

(active market competitors in

base year)

Competitor Overview Industry Advancement

*About 10 with revenue greater than $1.0 million USD

Executive Summary—Market Engineering Measurements

(continued)

Stable IncreasingDecreasing

Note: All figures are rounded. The base year is 2012. Source: Frost & Sullivan


7/79NC3F-54

2Shorter recovery time for products likeliquid embolics is an attractive optionfor hospitals looking to cut costs.

3 Growth through mergers andacquisitions is a growing trend toacquire niche technologies.

4

Published data on new clinical trials will

motivate physicians and surgeons touse new methods of treatment.

5Flow diversion devices are a loomingthreat to the coils market, due to their

benefits in wide-neck aneurysms.

1Rising ischemic stroke prevalencerepresents a largely unpenetratedmarket for solution providers.

Executive Summary—CEO’s Perspective


us neurovascular intervention market

Documents